Crescent Formulations Private Limited, a active private limited company, was established on 28 October 2010 in Hyderabad, Telangana, India. Engaging in wholesale within the trade sector, it holds CIN: U24232TG2010PTC070991. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.30 Cr.
It upholds a compliant status. Employing 171 professional, Its leadership includes Javeed Shaik (Director), Shaik Junaid (Director), Shaik Janimiya (Director). Past directors included Satya Venkata Raghava Subba Rao Chaganti. It holds ₹9.90 Cr open charges and ₹12.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4-7-11/4/C, Crescent Towers Raghavendra Nagar, Nacharam, Hyderabad, Telangana, 500076.
U24232TG2010PTC070991
070991
28 October 2010
₹2.50 Cr
₹2.30 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Crescent Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Javeed Shaik | Director | 24 Feb 2017 | Current |
| Shaik Junaid | Director | 04 May 2023 | Current |
| Shaik Janimiya | Director | 28 Oct 2010 | Current |
| Shaik Thahera | Director | 28 Oct 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Feb 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Crescent Formulations Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.2% decrease. The company also saw a substantial fall in profitability, with a 29.57% decrease in profit. The company's net worth Soared by an impressive increase of 10.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Crescent Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹99,000,000.00
₹119,967,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2023 | Hdfc Bank Limited | ₹4.00 M | Open |
| 08 Feb 2023 | Others | ₹4.00 Cr | Open |
| 07 Jun 2011 | Others | ₹5.50 Cr | Open |
| 08 Feb 2023 | Hdfc Bank Limited | ₹10.09 Cr | Satisfied |
| 23 Sep 2020 | Others | ₹9.60 M | Satisfied |
Explore comprehensive loan charge details -
Crescent Formulations has a workforce of 171 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Crescent Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crescent Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 17 Mar 2020 via Charge ID 100391592 with Axis Bank Limited was fully satisfied on 15 Jul 2025. was recorded as a recent event.
A charge registered on 23 Sep 2020 via Charge ID 100389060 with Others was fully satisfied on 05 Jul 2025. was recorded as a recent event.
The activity A charge registered on 09 Jul 2020 via Charge ID 100389061 with Others was fully satisfied on 05 Jul 2025. was completed.
Progress on A charge registered on 08 Feb 2023 via Charge ID 100708405 with Hdfc Bank Limited was fully satisfied on 14 May 2025. was documented.
The activity Crescent Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Crescent Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The CIN of Crescent Formulations Private Limited is U24232TG2010PTC070991.
Crescent Formulations Private Limited is headquartered at 4-7-11/4/C, Crescent Towers Raghavendra Nagar, Nacharam, Hyderabad, Telangana, 500076.
Crescent Formulations Private Limited was incorporated on 28 October 2010.
The current directors of Crescent Formulations Private Limited are
The primary industry of Crescent Formulations Private Limited is Trade.
Crescent Formulations Private Limited is unlisted.
The authorized capital of Crescent Formulations Private Limited is ₹2.50 Cr, and the paid-up capital is ₹2.30 Cr.
The compliance status of Crescent Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX